Unknown

Dataset Information

0

Euthyroid Sick Syndrome as a Prognostic Indicator of COVID-19 Pulmonary Involvement, Associated With Poorer Disease Prognosis and Increased Mortality.


ABSTRACT:

Objective

The prevalence of euthyroid sick syndrome (ESS) and its association with the prognosis of COVID-19 and mortality in patients with lung involvement in COVID-19 have not yet been elucidated.

Methods

Clinical and laboratory data of patients with COVID-19 with or without ESS were collected retrospectively and analyzed on admission. All subjects were admitted to the Department of Internal Diseases and Clinical Pharmacology at Bieganski Hospital between December 2020 and April 2021.

Results

In total, 310 medical records of patients with COVID-19 were analyzed retrospectively. Among 215 enrolled patients, 82 cases of ESS were diagnosed. The patients with ESS had higher pro-inflammatory factor levels, longer hospitalizations, and a higher risk of requiring high-flow nasal oxygen therapy or intubation than the patients without ESS. The Kaplan-Meier curve indicated that the patients with ESS had a lower probability of survival when computed tomography showed ≤50% parenchymal involvement compared with that in patients without ESS. However, no differences in mortality were noted in those with more than 50% parenchymal involvement. The survival curve showed that ESS was associated with a higher risk of mortality during hospitalization.

Conclusion

ESS is closely associated with a poor prognosis, including longer hospitalizations, more frequent intubation, transfer to the intensive care unit, and a higher mortality rate in patients with COVID-19. ESS is a potential prognostic predictor of survival, regardless of lung involvement in COVID-19.

SUBMITTER: Swistek M 

PROVIDER: S-EPMC8861257 | biostudies-literature | 2022 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Euthyroid Sick Syndrome as a Prognostic Indicator of COVID-19 Pulmonary Involvement, Associated With Poorer Disease Prognosis and Increased Mortality.

Świstek Magdalena M   Broncel Marlena M   Gorzelak-Pabiś Paulina P   Morawski Przemysław P   Fabiś Mateusz M   Woźniak Ewelina E  

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 20220222 5


<h4>Objective</h4>The prevalence of euthyroid sick syndrome (ESS) and its association with the prognosis of COVID-19 and mortality in patients with lung involvement in COVID-19 have not yet been elucidated.<h4>Methods</h4>Clinical and laboratory data of patients with COVID-19 with or without ESS were collected retrospectively and analyzed on admission. All subjects were admitted to the Department of Internal Diseases and Clinical Pharmacology at Bieganski Hospital between December 2020 and April  ...[more]

Similar Datasets

| S-EPMC10448823 | biostudies-literature
| S-EPMC4391833 | biostudies-literature
| S-EPMC9887577 | biostudies-literature
| S-EPMC11240374 | biostudies-literature
2019-10-26 | GSE121849 | GEO
| S-EPMC9704823 | biostudies-literature
| S-EPMC8632565 | biostudies-literature
| S-EPMC3664987 | biostudies-other
| S-EPMC6489948 | biostudies-literature
| S-EPMC10981250 | biostudies-literature